About Invivoscribe

invivoscribe.com

Invivoscribe is a company providing molecular products and services for leukemia and lymphoma testing.

Revenue : 50M-100M Industry : Biotechnology Location : United States Employees : 200-500

SaaS Adoption

SaaS Adoption indicates the level of adoption by this company of software as a service services.

Cloud Adoption

Cloud Adoption indicates the level of adoption by this company of cloud services.

IT Footprint

IT Footprint gives a relative indication of how much IT services this company consumes.

IT Spend

IT Spend shows roughly how much this client spends on IT per year in USD.

Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.

Know the products your prospects use

Enlyft provides you with access to our real-time data platform where you can access insights into a company’s tech stack, firmographic data, and more.

Vendor Usage

Invivoscribe uses 5 different technologies from 38 different vendors. They have above average use of several technologies including VMware ESX, VMware vSphere Hypervisor and Illumina DNA Sequencing.

Product Categories

Invivoscribe uses products from 40 different product categories. They are particularly heavy users of products in Backup Software, Web Analytics, and Email Communications Technologies.

Recently Detected Technologies

Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.

Technology Category Vendor Usage
VMware ESX Virtualization Platforms VMware, Inc
VMware vSphere Hypervisor Virtualization Platforms VMware, Inc
MobileIron Mobile Device Management MobileIron
CrashPlan Backup Software CrashPlan
Linux Operating Systems The Linux Foundation

Are you interested in knowing other companies with similar tech stacks?

Reveal what vendors your prospects are using

Enlyft Sales Insights gives you instant access to the tech stack and firmographics of millions of companies worldwide.
Logos provided by Clearbit

© Enlyft | All rights reserved.